Therapy: A local approach to Raynaud phenomenon.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 19412190.
- Also identified by DOI 10.1038/nrrheum.2009.64.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The current treatment options for Raynaud phenomenon are often ineffective and can have undesirable adverse effects. Topical, or transdermal, treatments that increase digital blood flow without systemic adverse effects are, therefore, an attractive option. A novel topical nitroglycerin formulation has shown promise in treating Raynaud attacks.
Medical subject headings
- Nitroglycerin
- Raynaud Disease
- Vasodilator Agents